← Open Payments lookup

KINSIE FISHER: Open Payments

NPI 1306254131 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,642 in 89 payments from 15 companies in 2025. Trend: 2023 $1,031 · 2024 $1,188 · 2025 $1,642

Food & beverage: $1,642
CompanyPaymentsAmount
ABBVIE INC.31$465
Takeda Pharmaceuticals U.S.A., Inc.14$246
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$221
Madrigal Pharmaceuticals5$184
Janssen Biotech, Inc.5$119
GENZYME CORPORATION4$105
Ferring Pharmaceuticals Inc.4$74
Lilly USA, LLC3$61
Ardelyx, Inc.2$35
Phathom Pharmaceuticals, Inc.3$35

Products named: XIFAXAN, ENTYVIO, RINVOQ, REZDIFFRA, DUPIXENT, TREMFYA, LINZESS, REBYOTA.

Industry payments across IN — which companies pay providers there.